Abstract

Phaeanthus ophthalmicus (Roxb. ex G.Don) J.Sinclair (previously known as P. ebracteolatus (Presl) Merr) is a Philippine medicinal plant occurring as evergreen shrub in the lowland forests of Luzon islands. It is used traditionally by Filipinos to treat bacterial conjunctivitis, ulcer and wound infections. Based on previous investigations where cyclooxygenase-2 (COX-2) functions as immune-linked factor in infectious sensitivities to bacterial pathogens by triggering pro-inflammatory immune-associated reactions, we investigated the antimicrobial and COX inhibitory activities of the extracts and tetrahydrobisbenzylisoquinoline alkaloids of P. ophthalmicus in vitro and in silico to validate its ethnomedicinal uses. Thus, the dichloromethane–methanol (DCM–MeOH) crude extract and alkaloid extracts exhibiting antibacterial activities against drug-resistant bacterial strains such as methicillin-resistance Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), Klebsiella pneumoniae + CRE and Pseudomonas aeruginosa + MBL afforded (+)-tetrandrine (1) and (+)-limacusine (2) as the major biologically active tetrahydrobisbenzylisoquinoline alkaloidal constituents after purification. Both tetrahydrobisbenzylisoquinoline alkaloids 1 and 2 showed broad spectrum antibacterial activity with strongest inhibition against the Gram-negative bacteria MβL-Pseudomonas aeruginosa Klebsiella pneumoniae + CRE. Interestingly, the alkaloid limacusine (2) showed selective inhibition against ovine COX-2 in vitro. These results were ascertained by molecular docking and molecular dynamics simulation experiments where alkaloid 2 showed strong affinity in the catalytic sites of Gram-negative bacterial enzymes P. aeruginosa elastase and K. pneumoniae KPC-2 carbapenemase (enzymes involved in infectivity mechanisms), and of ovine COX-2. Overall, our study provides credence on the ethnomedicinal use of the Philippine medicinal plant P. ophthalmicus as traditional plant-based adjuvant to treat bacterial conjunctivitis and other related infections. The antibacterial activities and selective COX-2 inhibition observed for limacusine (2) point to its role as the biologically active constituent of P. ophthalmicus. A limited number of drugs with COX-2 inhibitory properties like celecoxib also confer antibacterial activity. Thus, tetrahydrobisbenzyl alkaloids, especially 2, are promising pharmaceutical inspirations for developing treatments of bacterial/inflammation-related infections.

Highlights

  • The resurgence of infections caused by multi-drug resistant bacterial pathogens poses great threats globally and constitutes a major crisis plaguing societies in the past years [1]

  • The present study demonstrated the antibacterial and anti-inflammatory potentials of tetrahydrobisbenzylisoquinoline alkaloids especially limacusine (2) as well as the crude extracts and alkaloid sub-extracts of the Philippine medicinal plant Phaeanthus ophthalmicus

  • The results of our work are consistent with other studies implicating the relevance of COX2 inhibition with antibacterial activity

Read more

Summary

Introduction

The resurgence of infections caused by multi-drug resistant bacterial pathogens poses great threats globally and constitutes a major crisis plaguing societies in the past years [1]. Many pathogenic bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa exhibit multi-drug resistance (MDR). Recent efforts illustrate COX-2 inhibitors (i.e., celecoxib) confer increased bacterial sensitization and reversal of drug resistance [5,6]. This antibiotic drug discovery strategy plays a significant role in finding treatments for inflammatory-associated infections such as bacterial conjunctivitis and corneal ulcers. The extracts of the anti-inflammatory plant Calendula officinalis are applied topically to treat conjunctivitis [8] while extracts of Jasminum flowers possess antibacterial and antifungal properties relevant for treating inflamed eyes [9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call